These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10070673)

  • 1. Construction of uniform-balanced cross-over designs for any odd number of treatments.
    Prescott P
    Stat Med; 1999 Feb; 18(3):265-72. PubMed ID: 10070673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequentially balanced three-squares cross-over designs.
    Newcombe RG
    Stat Med; 1996 Oct; 15(20):2143-7. PubMed ID: 8910959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balanced designs for multiple crossover studies.
    Gaus W; Högel J
    Arzneimittelforschung; 1992 Feb; 42(2):163-72. PubMed ID: 1610429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling and design of cross-over trials.
    Jones B; Donev AN
    Stat Med; 1996 Jul; 15(13):1435-46. PubMed ID: 8841653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CrossOver: an algorithm for the construction of efficient cross-over designs.
    John JA; Russell KG; Whitaker D
    Stat Med; 2004 Sep; 23(17):2645-58. PubMed ID: 15316948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of several antibiotic formulations using a design based on a combination of balanced incomplete blocks and Latin squares.
    Prescott P; Ryan J; Shuttleworth P
    Stat Med; 1994 Jan; 13(1):11-21. PubMed ID: 9061837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal and efficient crossover designs under different assumptions about the carryover effects.
    Hedayat AS; Stufken J
    J Biopharm Stat; 2003 Aug; 13(3):519-28. PubMed ID: 12921398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tests for the analysis of variance of crossover designs with correlated errors.
    Bellavance F; Tardif S; Stephens MA
    Biometrics; 1996 Jun; 52(2):607-12. PubMed ID: 8672705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatially balanced sampling designs for environmental surveys.
    Kermorvant C; D'Amico F; Bru N; Caill-Milly N; Robertson B
    Environ Monit Assess; 2019 Jul; 191(8):524. PubMed ID: 31363924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal designs for evaluating a series of treatments.
    Leung DH; Wang YG
    Biometrics; 2001 Mar; 57(1):168-71. PubMed ID: 11252593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical methods for two-sequence three-period cross-over designs with incomplete data.
    Chow SC; Shao J
    Stat Med; 1997 May; 16(9):1031-9. PubMed ID: 9160497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Split-mouth and cross-over designs in dental research.
    Antczak-Bouckoms AA; Tulloch JF; Berkey CS
    J Clin Periodontol; 1990 Aug; 17(7 Pt 1):446-53. PubMed ID: 2201705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of balanced treatment allocation for survival analysis.
    Kalish LA; Harrington DP
    Biometrics; 1988 Sep; 44(3):815-21. PubMed ID: 3203130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robustness of crossover trials against subject drop-out - Examples of perpetually connected designs.
    Godolphin PJ; Godolphin EJ
    Stat Methods Med Res; 2019 Mar; 28(3):788-800. PubMed ID: 29145768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossover designs with correlated observations.
    Donev AN
    J Biopharm Stat; 1998 May; 8(2):249-62. PubMed ID: 9598421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal and/or efficient three treatment crossover designs for five carryover models.
    Gondaliya J; Divecha J
    J Biopharm Stat; 2020 May; 30(3):445-461. PubMed ID: 31721628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and interpretation of results for three cross-over designs.
    Guiard V; Spilke J; Dänicke S
    Arch Tierernahr; 2003 Jun; 57(3):177-95. PubMed ID: 12903863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic estimators with moderating influence: the carry-over in cross-over trials revisited.
    Longford NT
    Stat Med; 2001 Nov; 20(21):3189-203. PubMed ID: 11746312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
    Liu Q; Li G; Anderson KM; Lim P
    J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal and/or Efficient Two treatment Crossover Designs for Five Carryover Models.
    Gondaliya J; Divecha J
    Int J Biostat; 2018 Nov; 14(2):. PubMed ID: 30471221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.